BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Jeff Collins to sit on a panel titled "Investing in Neurotech" at The Neurotech Industry Investing and Partnering Conference in Boston, MA
News | 05. 08. 2008
